1. Home
  2. NVAX vs NEXT Comparison

NVAX vs NEXT Comparison

Compare NVAX & NEXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • NEXT
  • Stock Information
  • Founded
  • NVAX 1987
  • NEXT 2010
  • Country
  • NVAX United States
  • NEXT United States
  • Employees
  • NVAX N/A
  • NEXT N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • NEXT Oil & Gas Production
  • Sector
  • NVAX Health Care
  • NEXT Energy
  • Exchange
  • NVAX Nasdaq
  • NEXT Nasdaq
  • Market Cap
  • NVAX 2.0B
  • NEXT 1.4B
  • IPO Year
  • NVAX 1995
  • NEXT N/A
  • Fundamental
  • Price
  • NVAX $9.76
  • NEXT $5.93
  • Analyst Decision
  • NVAX Buy
  • NEXT Hold
  • Analyst Count
  • NVAX 6
  • NEXT 1
  • Target Price
  • NVAX $17.83
  • NEXT $9.00
  • AVG Volume (30 Days)
  • NVAX 7.2M
  • NEXT 1.1M
  • Earning Date
  • NVAX 11-07-2024
  • NEXT 11-11-2024
  • Dividend Yield
  • NVAX N/A
  • NEXT N/A
  • EPS Growth
  • NVAX N/A
  • NEXT N/A
  • EPS
  • NVAX N/A
  • NEXT N/A
  • Revenue
  • NVAX $987,667,000.00
  • NEXT N/A
  • Revenue This Year
  • NVAX N/A
  • NEXT N/A
  • Revenue Next Year
  • NVAX N/A
  • NEXT N/A
  • P/E Ratio
  • NVAX N/A
  • NEXT N/A
  • Revenue Growth
  • NVAX N/A
  • NEXT N/A
  • 52 Week Low
  • NVAX $3.53
  • NEXT $4.01
  • 52 Week High
  • NVAX $23.86
  • NEXT $8.52
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 36.20
  • NEXT 63.68
  • Support Level
  • NVAX $9.52
  • NEXT $5.35
  • Resistance Level
  • NVAX $10.63
  • NEXT $5.98
  • Average True Range (ATR)
  • NVAX 0.57
  • NEXT 0.27
  • MACD
  • NVAX -0.12
  • NEXT 0.04
  • Stochastic Oscillator
  • NVAX 9.97
  • NEXT 79.22

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About NEXT NextDecade Corporation

NextDecade Corp is a energy company predominantly engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The company provides a number of services depending on the individual needs of the customer. These include the supply and trade of LNG volumes, the creation of new natural gas infrastructure including pipeline and natural gas liquefaction facilities, treatment and processing of natural gas into LNG, as well as technical engineering and design services related to the development and execution of natural gas infrastructure, transporting, shipping and storage of LNG.

Share on Social Networks: